22-26625437-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001886.3(CRYBA4):​c.159-44G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.153 in 1,607,116 control chromosomes in the GnomAD database, including 20,966 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.15 ( 2078 hom., cov: 32)
Exomes 𝑓: 0.15 ( 18888 hom. )

Consequence

CRYBA4
NM_001886.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.0830

Publications

15 publications found
Variant links:
Genes affected
CRYBA4 (HGNC:2396): (crystallin beta A4) Crystallins are separated into two classes: taxon-specific, or enzyme, and ubiquitous. The latter class constitutes the major proteins of vertebrate eye lens and maintains the transparency and refractive index of the lens. Since lens central fiber cells lose their nuclei during development, these crystallins are made and then retained throughout life, making them extremely stable proteins. Mammalian lens crystallins are divided into alpha, beta, and gamma families; beta and gamma crystallins are also considered as a superfamily. Alpha and beta families are further divided into acidic and basic groups. Seven protein regions exist in crystallins: four homologous motifs, a connecting peptide, and N- and C-terminal extensions. Beta-crystallins, the most heterogeneous, differ by the presence of the C-terminal extension (present in the basic group, none in the acidic group). Beta-crystallins form aggregates of different sizes and are able to self-associate to form dimers or to form heterodimers with other beta-crystallins. This gene, a beta acidic group member, is part of a gene cluster with beta-B1, beta-B2, and beta-B3. [provided by RefSeq, Jul 2008]
CRYBA4 Gene-Disease associations (from GenCC):
  • cataract 23
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • cataract - microcornea syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • early-onset lamellar cataract
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 22-26625437-G-A is Benign according to our data. Variant chr22-26625437-G-A is described in ClinVar as Benign. ClinVar VariationId is 677231.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.37 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CRYBA4NM_001886.3 linkc.159-44G>A intron_variant Intron 3 of 5 ENST00000354760.4 NP_001877.1 P53673A0A097PIJ6
CRYBA4XM_006724140.4 linkc.174-44G>A intron_variant Intron 5 of 7 XP_006724203.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CRYBA4ENST00000354760.4 linkc.159-44G>A intron_variant Intron 3 of 5 1 NM_001886.3 ENSP00000346805.3 P53673
CRYBA4ENST00000466315.1 linkn.56-44G>A intron_variant Intron 2 of 4 5

Frequencies

GnomAD3 genomes
AF:
0.155
AC:
23509
AN:
152008
Hom.:
2076
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.132
Gnomad AMI
AF:
0.195
Gnomad AMR
AF:
0.172
Gnomad ASJ
AF:
0.196
Gnomad EAS
AF:
0.383
Gnomad SAS
AF:
0.254
Gnomad FIN
AF:
0.132
Gnomad MID
AF:
0.136
Gnomad NFE
AF:
0.141
Gnomad OTH
AF:
0.152
GnomAD2 exomes
AF:
0.181
AC:
44975
AN:
248440
AF XY:
0.181
show subpopulations
Gnomad AFR exome
AF:
0.132
Gnomad AMR exome
AF:
0.183
Gnomad ASJ exome
AF:
0.206
Gnomad EAS exome
AF:
0.391
Gnomad FIN exome
AF:
0.135
Gnomad NFE exome
AF:
0.145
Gnomad OTH exome
AF:
0.161
GnomAD4 exome
AF:
0.152
AC:
221583
AN:
1454990
Hom.:
18888
Cov.:
29
AF XY:
0.155
AC XY:
112149
AN XY:
723622
show subpopulations
African (AFR)
AF:
0.136
AC:
4530
AN:
33364
American (AMR)
AF:
0.179
AC:
8001
AN:
44598
Ashkenazi Jewish (ASJ)
AF:
0.208
AC:
5419
AN:
26020
East Asian (EAS)
AF:
0.393
AC:
15549
AN:
39584
South Asian (SAS)
AF:
0.236
AC:
20290
AN:
86002
European-Finnish (FIN)
AF:
0.138
AC:
7094
AN:
51338
Middle Eastern (MID)
AF:
0.172
AC:
992
AN:
5756
European-Non Finnish (NFE)
AF:
0.135
AC:
150082
AN:
1108158
Other (OTH)
AF:
0.160
AC:
9626
AN:
60170
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
7679
15358
23038
30717
38396
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5610
11220
16830
22440
28050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.155
AC:
23512
AN:
152126
Hom.:
2078
Cov.:
32
AF XY:
0.157
AC XY:
11649
AN XY:
74370
show subpopulations
African (AFR)
AF:
0.131
AC:
5455
AN:
41512
American (AMR)
AF:
0.172
AC:
2634
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.196
AC:
680
AN:
3468
East Asian (EAS)
AF:
0.384
AC:
1974
AN:
5146
South Asian (SAS)
AF:
0.254
AC:
1222
AN:
4810
European-Finnish (FIN)
AF:
0.132
AC:
1399
AN:
10612
Middle Eastern (MID)
AF:
0.143
AC:
42
AN:
294
European-Non Finnish (NFE)
AF:
0.141
AC:
9612
AN:
67972
Other (OTH)
AF:
0.150
AC:
317
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
982
1964
2945
3927
4909
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
266
532
798
1064
1330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.149
Hom.:
7727
Bravo
AF:
0.155
Asia WGS
AF:
0.241
AC:
836
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 19, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
5.4
DANN
Benign
0.72
PhyloP100
-0.083
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2071862; hg19: chr22-27021401; COSMIC: COSV61321282; API